US Patent 11753458 CTLA-4 variant immunomodulatory proteins and uses thereof
Patent 11753458 was granted and assigned to ALPINE IMMUNE SCIENCES, INC. on September, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11753458 CTLA-4 variant immunomodulatory proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
